The August 2025 policy change excludes all weight-related indications
While it can contribute to weight loss, its not officially approved for it
Anything else is marketing until proven otherwise Higher doses can cause GI issues for some people
Micro-CT analysis of the lower end-plate of the upper vertebral body and the upper end-plate of the lower vertebral body showed significant increases in bone volume (BV/TV) in IVDs that received needle puncture only
I think its important to note, however, that this does not invalidate the initial weight loss or the potential popularity of these drugs - nor the chances that patients may stay on them indefinitely
Any discoloration, unusual odor, excessive powdering, or tablets that appear to be breaking down or sticking together may indicate degradation and the medication should not be used